Be Aware of the Pitfalls in the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis



Be Aware of the Pitfalls in the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis


Vijay A. Singh MD

Stephen M. Milner MD, FACS



There is controversy about the classification of Stevens-Johnson syndrome and toxic epidermal necrolysis. These rare but potentially debilitating dermatologic abnormalities have a mortality rate as high as 40%. The debate has centered on whether these conditions are related or separate entities. Current consensus is that they are variants of the same disease with differing severities, with the extent of epidermal detachment being the key component to its classification. A practical clinical classification considers less than 10% of the total body surface area involved to indicate Stevens-Johnson syndrome. If the epidermal detachment involves more than 30% of the total body surface area, then toxic epidermal necrolysis is the presumed diagnosis. An area between 10% and 30% is less definitive and is considered to represent Stevens-Johnson syndrome and toxic epidermal necrolysis overlap.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 1, 2016 | Posted by in ANESTHESIA | Comments Off on Be Aware of the Pitfalls in the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access